Haemophilus influenzae type b conjugate vaccine (Beijing Minhai Biotechnology)

b型流感嗜血杆菌结合疫苗（北京民海）

Report date: 2022/10/18 16:43:23

Base Information

Drug NameHaemophilus influenzae type b conjugate vaccine (Beijing Minhai Biotechnology)
Drug Alias NameMinhai-HIB
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisHaemophilus Infections
Global Approved IndicationsHaemophilus Infections
Approved Indications in ChinaHaemophilus Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2012/03/23
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Minhai Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Minhai Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHaemophilus Infections
Inactive IndicationsMeningitis

Other Information

ATC CodeJ07BB
Related LinksWikipedia